237 related articles for article (PubMed ID: 9463786)
1. Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes?
Wiesenfeld-Hallin Z
Drugs; 1998 Jan; 55(1):1-4. PubMed ID: 9463786
[TBL] [Abstract][Full Text] [Related]
2. Ketamine in cancer pain: an update.
Mercadante S
Palliat Med; 1996 Jul; 10(3):225-30. PubMed ID: 8817593
[TBL] [Abstract][Full Text] [Related]
3. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
Fischer BD; Carrigan KA; Dykstra LA
J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
[TBL] [Abstract][Full Text] [Related]
4. A qualitative systematic review of the role of N-methyl-D-aspartate receptor antagonists in preventive analgesia.
McCartney CJ; Sinha A; Katz J
Anesth Analg; 2004 May; 98(5):1385-400, table of contents. PubMed ID: 15105220
[TBL] [Abstract][Full Text] [Related]
5. The importance of the number of NMDA receptors in the development of supersensitivity or tolerance to and dependence on morphine.
Koyuncuoglu H; Nurten A; Yamantürk P; Nurten R
Pharmacol Res; 1999 Apr; 39(4):311-9. PubMed ID: 10208762
[TBL] [Abstract][Full Text] [Related]
6. Complete prevention but stimulus-dependent reversion of morphine tolerance by the glycine/NMDA receptor antagonist (+)-HA966 in neuropathic rats.
Christensen D; Guilbaud G; Kayser V
Anesthesiology; 2000 Mar; 92(3):786-94. PubMed ID: 10719957
[TBL] [Abstract][Full Text] [Related]
7. The use of NMDA-receptor antagonists in the treatment of chronic pain.
Hewitt DJ
Clin J Pain; 2000 Jun; 16(2 Suppl):S73-9. PubMed ID: 10870744
[TBL] [Abstract][Full Text] [Related]
8. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo.
Warncke T; Stubhaug A; Jørum E
Pain; 1997 Aug; 72(1-2):99-106. PubMed ID: 9272793
[TBL] [Abstract][Full Text] [Related]
9. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain.
Rabben T; Skjelbred P; Oye I
J Pharmacol Exp Ther; 1999 May; 289(2):1060-6. PubMed ID: 10215688
[TBL] [Abstract][Full Text] [Related]
10. Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways.
Chizh BA
J Psychopharmacol; 2007 May; 21(3):259-71. PubMed ID: 17591654
[TBL] [Abstract][Full Text] [Related]
11. NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials.
Sang CN
J Pain Symptom Manage; 2000 Jan; 19(1 Suppl):S21-5. PubMed ID: 10687335
[TBL] [Abstract][Full Text] [Related]
12. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
[TBL] [Abstract][Full Text] [Related]
13. Large-dose oral dextromethorphan as an adjunct to patient-controlled analgesia with morphine after knee surgery.
Wadhwa A; Clarke D; Goodchild CS; Young D
Anesth Analg; 2001 Feb; 92(2):448-54. PubMed ID: 11159249
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacotherapy for acute postoperative pain based on use of NMDA receptors-associated drugs].
Ovechkin AM; Efremenko IV
Anesteziol Reanimatol; 2013; (3):63-9. PubMed ID: 24341000
[No Abstract] [Full Text] [Related]
15. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.
Allen RM; Dykstra LA
J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554
[TBL] [Abstract][Full Text] [Related]
16. [Low doses ketamine: antihyperalgesic drug, non-analgesic].
Richebé P; Rivat C; Rivalan B; Maurette P; Simonnet G
Ann Fr Anesth Reanim; 2005; 24(11-12):1349-59. PubMed ID: 16115745
[TBL] [Abstract][Full Text] [Related]
17. [Development of opioid tolerance -- molecular mechanisms and clinical consequences].
Freye E; Latasch L
Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice.
Kozela E; Pilc A; Popik P
Psychopharmacology (Berl); 2003 Jan; 165(3):245-51. PubMed ID: 12442203
[TBL] [Abstract][Full Text] [Related]
19. Combined systemic administration of the glycine/NMDA receptor antagonist, (+)-HA966 and morphine attenuates pain-related behaviour in a rat model of trigeminal neuropathic pain.
Christensen D; Gautron M; Guilbaud G; Kayser V
Pain; 1999 Dec; 83(3):433-440. PubMed ID: 10568851
[TBL] [Abstract][Full Text] [Related]
20. [NMDA-receptor antagonist in pain therapy].
Weber C
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Aug; 33(8):475-83. PubMed ID: 9746842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
